Sather Financial Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-47,071
Closed -$4.65M 66
2017
Q3
$4.65M Sell
47,071
-3,375
-7% -$327K 1.27% 30
2017
Q2
$5.11M Sell
50,446
-3,541
-7% -$382K 1.47% 30
2017
Q1
$6.24M Sell
53,987
-358
-0.7% -$41.6K 1.95% 24
2016
Q4
$6.52M Sell
54,345
-275
-0.5% -$30.4K 2.25% 23
2016
Q3
$6.13M Sell
54,620
-1,138
-2% -$131K 2.34% 19
2016
Q2
$6.91M Sell
55,758
-787
-1% -$95K 2.68% 16
2016
Q1
$6.36M Buy
56,545
+5,456
+11% +$567K 2.56% 16
2015
Q4
$5.55M Sell
51,089
-4,150
-8% -$475K 2.33% 19
2015
Q3
$5.51M Buy
55,239
+7,371
+15% +$802K 2.24% 20
2015
Q2
$5.46M Sell
47,868
-5,850
-11% -$709K 2.31% 23
2015
Q1
$5.6M Buy
+53,718
New +$5.72M 2.44% 21

Other funds holding CLB

Sather Financial Group's CLB Position: Q4 2017 in Review

Sather Financial Group sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 47,071 shares — an estimated $4.65M sold.

Sather Financial Group first reported a position in CLB in Q1 2015 and held it in 11 quarters. The position peaked at $6.91M in Q2 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Sather Financial Group reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Sather Financial Group sold 47,071 Core Laboratories shares in Q4 2017, an estimated $4.65M.
  • Sather Financial Group first reported a position in Core Laboratories in Q1 2015 and held it in 11 quarters.
  • Sather Financial Group's Core Laboratories position peaked at $6.91M in Q2 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Sather Financial Group's 13F filing for Q4 2017, filed 15 Feb 2018.